Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Bayliss

Showing results (11-20 of 55) with videos related to

Pageof 6
Sort By:
Health Technology Assessment (Winchester, England)|May 29, 2010
Cetuximab for the first-line treatment of metastatic colorectal cancerC Meads, J Round, S Tubeuf, et al.
Health Technology Assessment (Winchester, England)|May 29, 2010
Sorafenib for the treatment of advanced hepatocellular carcinomaM Connock, J Round, S Bayliss, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|December 4, 2003
Usefulness of the SF-8 Health Survey for comparing the impact of migraine and other conditionsDiane M Turner-Bowker, Martha S Bayliss, John E Ware, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|January 1, 2014
Measurement properties of the flu-like symptom index from the hepatitis physical symptom severity diarySusan Mathias, Ross D Crosby, Martha S Bayliss, et al.
British Medical Journal|June 5, 1976
Non-accidental injury in children: what we do in DerbyL J Arthur, W M Moncrieff, W Milburn, et al.
Health Technology Assessment (Winchester, England)|November 5, 2010
Rituximab for the treatment of relapsed/refractory chronic lymphocytic leukaemiaJ Dretzke, P Barton, B Kaambwa, et al.
Patient Related Outcome Measures|August 24, 2012
Development of a questionnaire to assess experience and preference of intranasal corticosteroids in patients with allergic rhinitisBruce Crawford, Richard H Stanford, Audrey Y Wong, et al.
Patient Related Outcome Measures|August 24, 2012
Psychometric validation of the experience with allergic rhinitis nasal spray questionnaireBruce Crawford, Richard H Stanford, Audrey Y Wong, et al.
Patient Related Outcome Measures|December 22, 2017
Psychometric validation of the SF-36 Health Survey in light chain amyloidosis: results from community-based and clinic-based samplesMichelle K White, Kristen L McCausland, Vaishali Sanchorawala, et al.
JAMA|October 2, 1996
Differences in 4-year health outcomes for elderly and poor, chronically ill patients treated in HMO and fee-for-service systems. Results from the Medical Outcomes StudyJ E Ware, M S Bayliss, W H Rogers, et al.
Pageof 6

Showing results (11-20 of 55) with videos related to

Sort By:
Pageof 6
Health Technology Assessment (Winchester, England)|May 29, 2010
Cetuximab for the first-line treatment of metastatic colorectal cancerC Meads, J Round, S Tubeuf, et al.
Health Technology Assessment (Winchester, England)|May 29, 2010
Sorafenib for the treatment of advanced hepatocellular carcinomaM Connock, J Round, S Bayliss, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|December 4, 2003
Usefulness of the SF-8 Health Survey for comparing the impact of migraine and other conditionsDiane M Turner-Bowker, Martha S Bayliss, John E Ware, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|January 1, 2014
Measurement properties of the flu-like symptom index from the hepatitis physical symptom severity diarySusan Mathias, Ross D Crosby, Martha S Bayliss, et al.
British Medical Journal|June 5, 1976
Non-accidental injury in children: what we do in DerbyL J Arthur, W M Moncrieff, W Milburn, et al.
Health Technology Assessment (Winchester, England)|November 5, 2010
Rituximab for the treatment of relapsed/refractory chronic lymphocytic leukaemiaJ Dretzke, P Barton, B Kaambwa, et al.
Patient Related Outcome Measures|August 24, 2012
Development of a questionnaire to assess experience and preference of intranasal corticosteroids in patients with allergic rhinitisBruce Crawford, Richard H Stanford, Audrey Y Wong, et al.
Patient Related Outcome Measures|August 24, 2012
Psychometric validation of the experience with allergic rhinitis nasal spray questionnaireBruce Crawford, Richard H Stanford, Audrey Y Wong, et al.
Patient Related Outcome Measures|December 22, 2017
Psychometric validation of the SF-36 Health Survey in light chain amyloidosis: results from community-based and clinic-based samplesMichelle K White, Kristen L McCausland, Vaishali Sanchorawala, et al.
JAMA|October 2, 1996
Differences in 4-year health outcomes for elderly and poor, chronically ill patients treated in HMO and fee-for-service systems. Results from the Medical Outcomes StudyJ E Ware, M S Bayliss, W H Rogers, et al.
Pageof 6